Holen Sie sich die Stockscreener-App
78.44
0.37%
0.29
Vorhandelsmarkt:
78.44
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CVS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$78.15
Offen:
$78.06
24-Stunden-Volumen:
8.21M
Relative Volume:
1.15
Marktkapitalisierung:
$99.49B
Einnahmen:
$393.94B
Nettoeinkommen (Verlust:
$428.00M
KGV:
205.02
EPS:
0.3826
Netto-Cashflow:
$6.29B
1W Leistung:
-4.86%
1M Leistung:
+1.23%
6M Leistung:
+16.28%
1J Leistung:
+40.55%
1-Tages-Spanne:
$77.43
$78.78
1-Wochen-Bereich:
$75.92
$85.15
52-Wochen-Spanne:
$43.56
$85.15
Cvs Health Corp Stock (CVS) Company Profile
Firmenname
Cvs Health Corp
Sektor
Branche
Telefon
(401) 765-1500
Adresse
ONE CVS DR., WOONSOCKET
Vergleichen Sie CVS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
78.44 | 99.21B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
UNH
Unitedhealth Group Inc
|
333.79 | 309.40B | 435.16B | 18.37B | 17.37B | 19.16 |
|
ELV
Elevance Health Inc
|
313.19 | 70.49B | 194.82B | 5.53B | 3.77B | 24.45 |
|
CI
Cigna Group
|
258.62 | 65.29B | 268.22B | 6.55B | 7.44B | 22.67 |
|
HUM
Humana Inc
|
279.92 | 33.46B | 123.11B | 1.58B | 2.44B | 13.03 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-14 | Eingeleitet | Goldman | Buy |
| 2025-08-18 | Hochstufung | UBS | Neutral → Buy |
| 2025-08-14 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Hochstufung | Edward Jones | Hold → Buy |
| 2024-12-03 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-05-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-05-02 | Herabstufung | UBS | Buy → Neutral |
| 2024-05-01 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-22 | Eingeleitet | HSBC Securities | Buy |
| 2023-09-19 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Herabstufung | Edward Jones | Buy → Hold |
| 2023-05-26 | Eingeleitet | Piper Sandler | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Eingeleitet | Goldman | Buy |
| 2021-12-01 | Eingeleitet | Seaport Research Partners | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-03-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2020-09-17 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-05-14 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-06-05 | Hochstufung | Standpoint Research | Hold → Buy |
| 2019-04-29 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-04-15 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Bestätigt | BofA/Merrill | Buy |
| 2019-03-13 | Eingeleitet | Bernstein | Outperform |
| 2019-02-20 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2018-12-18 | Eingeleitet | Barclays | Overweight |
| 2018-11-29 | Fortgesetzt | Goldman | Neutral |
| 2018-11-28 | Eingeleitet | Evercore ISI | Outperform |
| 2018-10-26 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2018-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-02-13 | Bestätigt | Citigroup | Neutral |
Alle ansehen
Cvs Health Corp Aktie (CVS) Neueste Nachrichten
Bank of New York Mellon Corp Sells 325,652 Shares of CVS Health Corporation $CVS - MarketBeat
Hussman Strategic Advisors Inc. Takes $2.17 Million Position in CVS Health Corporation $CVS - MarketBeat
Is CVS Health Corporation stock supported by strong fundamentalsEarnings Growth Report & Low Risk Entry Point Guides - newser.com
Y Intercept Hong Kong Ltd Acquires New Position in CVS Health Corporation $CVS - MarketBeat
What the charts say about CVS Health Corporation todayJuly 2025 Trade Ideas & Smart Money Movement Alerts - newser.com
Is CVS Health Corporation (Common Stock) (CVS0) stock a safe buy pre earnings2025 Top Decliners & Low Risk Growth Stock Ideas - newser.com
Will CVS Health Corporation bounce back from current supportJuly 2025 Volume & Capital Efficient Trading Techniques - newser.com
CVS Health price target raised to $100 from $99 at TD Cowen - TipRanks
CVS Health: Undervalued And Ripe For Growth (NYSE:CVS) - Seeking Alpha
CVS Health Corporation $CVS Stake Lowered by Triglav Investments D.O.O. - MarketBeat
4,657 Shares in CVS Health Corporation $CVS Bought by Sebold Capital Management Inc. - MarketBeat
State of Michigan Retirement System Has $27.12 Million Position in CVS Health Corporation $CVS - MarketBeat
Is CVS Health Corporation stock affected by interest rate hikesMarket Performance Report & Growth Focused Investment Plans - newser.com
Is now a turning point for CVS Health Corporation2025 Major Catalysts & Real-Time Stock Entry Alerts - newser.com
How CVS Health Corporation (CVS) stock performs in easing cyclesProduct Launch & Safe Swing Trade Setup Alerts - newser.com
Is CVS Health Corporation stock a buy for dividend growth2025 EndofYear Setup & Stock Portfolio Risk Control - newser.com
Mesirow Financial Investment Management Inc. Decreases Position in CVS Health Corporation $CVS - MarketBeat
CVS Health Corp. Hits Day Low of $75.92 Amid Price Pressure - Markets Mojo
Will CVS Health Corporation (Common Stock) (CVS0) stock profit from fiscal stimulusPortfolio Gains Summary & Free Community Supported Trade Ideas - newser.com
Is CVS Health Corporation stock positioned for digital transformationJuly 2025 Macro Moves & Real-Time Volume Triggers - newser.com
CVS Health FY2025 EPS Estimate Boosted by Cantor Fitzgerald - MarketBeat
CVS Health Corp. Hits New 52-Week High of $85.15 - Markets Mojo
CVS Health Corporation $CVS Shares Sold by Fisher Funds Management LTD - MarketBeat
Assetmark Inc. Acquires 69,152 Shares of CVS Health Corporation $CVS - MarketBeat
Bessemer Group Inc. Cuts Position in CVS Health Corporation $CVS - MarketBeat
Is it time to cut losses on CVS Health CorporationPortfolio Update Summary & Consistent Profit Trading Strategies - newser.com
Short interest data insights for CVS Health CorporationMarket Activity Report & Real-Time Chart Breakout Alerts - newser.com
[13F-HR] CVS HEALTH Corp SEC Filing - Stock Titan
CVS Health (NYSE: CVS) customers give $3M; company commits $2M to Feeding America - Stock Titan
Evercore ISI Forecasts Strong Price Appreciation for CVS Health (NYSE:CVS) Stock - MarketBeat
Impact Partnership Wealth LLC Takes Position in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by Carret Asset Management LLC - MarketBeat
CVS Health Corporation $CVS Stock Position Trimmed by Daymark Wealth Partners LLC - MarketBeat
Is CVS Health Corporation stock in correction or buying zoneMarket Performance Summary & Accurate Intraday Trading Signals - newser.com
Will CVS Health Corporation (CVS) stock maintain strong growth2025 Price Momentum & Risk Controlled Stock Alerts - newser.com
Is CVS Health Corporation stock a top momentum playJuly 2025 Short Interest & Short-Term High Return Strategies - newser.com
Philly Accuses PBMs Of Knowingly Enabling Opioid Crisis - Law360
CVS Health to shut down 16 ‘underperforming' Oak Street Health clinics, including 1 in Chicago - MSN
Gilead posts higher profit on demand for HIV drugs, but overall sales dip - Reuters
CVS Stock Slips as $5.7 Billion Charge Overshadows Record Results - Yahoo! Finance Canada
CVS Stock: Evercore ISI Raises Price Target to $95, Maintains Ou - GuruFocus
Cardinal Health Inc. stock outperforms competitors on strong trading day - MarketWatch
CVS Health Grows Earnings And Outlook While Stock Stumbles - Finimize
Why CVS Health (CVS) Stock Is Falling Today - Barchart.com
CVS Health Corp (CVS) Q3 2025 Earnings Call Highlights: Strong R - GuruFocus
CVS Health to shut down 16 Oak Street Health clinics, including 1 in Chicago - NBC 5 Chicago
CVS Health (CVS) Rating Maintained by RBC Capital with Raised Pr - GuruFocus
CVS Health tops Q3 forecasts but absorbs hefty charge for struggling clinic business - Idaho Business Review
CVS Health (CVS): Cantor Fitzgerald Raises Price Target to $95 | - GuruFocus
CVS Health (CVS) Analyst Rating Update: Target Price Raised by T - GuruFocus
CVS Health Stock Feels the Heat as $5.7B Write-Down Weighs on ‘Record’ Q3 - TipRanks
Finanzdaten der Cvs Health Corp-Aktie (CVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.26%
5.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):